S Owen

442 total citations
9 papers, 233 citations indexed

About

S Owen is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Immunology. According to data from OpenAlex, S Owen has authored 9 papers receiving a total of 233 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pathology and Forensic Medicine, 3 papers in Molecular Biology and 3 papers in Immunology. Recurrent topics in S Owen's work include Multiple Sclerosis Research Studies (4 papers), Peptidase Inhibition and Analysis (2 papers) and Immune Response and Inflammation (2 papers). S Owen is often cited by papers focused on Multiple Sclerosis Research Studies (4 papers), Peptidase Inhibition and Analysis (2 papers) and Immune Response and Inflammation (2 papers). S Owen collaborates with scholars based in United Kingdom, Mexico and United States. S Owen's co-authors include Alan Davison, Marc Feldmann, Virginia L. Calder, Leslie Choi, D C Talbot, N C Levitt, Ferry A.L.M. Eskens, J M Wood, Masatoshi Nakajima and L. Denis and has published in prestigious journals such as Journal of Neurochemistry, Brain Behavior and Immunity and Clinical & Experimental Immunology.

In The Last Decade

S Owen

9 papers receiving 226 citations

Peers

S Owen

CR

ONCOL

MB

PFM

IMMUN

Cláudia Miranda Italy

Michael J. Ravitz United States

Priscilla Soulié Switzerland

Daniel J. Purcell United States

Madhan Thamilarasan Germany

Hun-Taek Kim United States

Samantha Gokhale United States

Ayten Kandilci United States

Katie E. Hebron United States

Ana Rita Lourenço Netherlands

Cláudia Miranda Italy

S Owen

52 ×0.5

CR

143 ×1.4

ONCOL

223 ×2.7

MB

39 ×0.8

PFM

37 ×0.8

IMMUN

Citations per year, relative to S Owen S Owen (= 1×) peers Cláudia Miranda

Countries citing papers authored by S Owen

Since Specialization

Citations

This map shows the geographic impact of S Owen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Owen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Owen more than expected).

Fields of papers citing papers by S Owen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Owen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Owen. The network helps show where S Owen may publish in the future.

Co-authorship network of co-authors of S Owen

This figure shows the co-authorship network connecting the top 25 collaborators of S Owen. A scholar is included among the top collaborators of S Owen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Owen. S Owen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Owen, S, et al.. (2016). The Impact of Lowering Haemoglobin Targets on Patterns of Erythropoiesis-Stimulating Agent Use in Patients on Haemodialysis. Blood Purification. 41(4). 287–292. 3 indexed citations

2.

Eatock, Martin, Jim Cassidy, Jason L. Johnson, et al.. (2004). A dose-finding and pharmacokinetic study of the matrix metalloproteinase inhibitor MMI270 (previously termed CGS27023A) with 5-FU and folinic acid. Cancer Chemotherapy and Pharmacology. 55(1). 39–46. 23 indexed citations

3.

Levitt, N C, Ferry A.L.M. Eskens, Kenneth J. O’Byrne, et al.. (2001). Phase I and pharmacological study of the oral matrix metalloproteinase inhibitor, MMI270 (CGS27023A), in patients with advanced solid cancer.. PubMed. 7(7). 1912–22. 106 indexed citations

4.

Owen, S, et al.. (1990). Degradation of human myelin in vitro by leucocytes from patients with multiple sclerosis. Clinical & Experimental Immunology. 82(1). 86–92. 4 indexed citations

5.

Calder, VL, et al.. (1989). Multiple sclerosis: a localised immune disease of the central nervous system. UCL Discovery (University College London). 2 indexed citations

6.

Calder, Virginia L., et al.. (1989). MS: a localized immune disease of the central nervous system. Immunology Today. 10(3). 99–103. 66 indexed citations

7.

Davison, Alan, et al.. (1988). Nervous and immune system disorders in multiple sclerosis. Brain Behavior and Immunity. 2(4). 335–340. 1 indexed citations

8.

Najbauer, József, et al.. (1988). An In Vitro Micromethod for the Quantitative Assessment of Central Demyelination. Journal of Neurochemistry. 50(5). 1469–1477. 9 indexed citations

9.

Calder, VL, S Owen, Cathryn M. Lewis, et al.. (1987). Effects of cyclosporin A on expression of IL-2 and IL-2 receptors in normal and multiple sclerosis patients.. PubMed. 70(3). 570–7. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact